Temporal Improvement in Outcomes of Surgical Treatment of Isolated Tricuspid Regurgitation in the United States
Recent advances in transcatheter interventionsrefueled the interest in tricuspid regurgitation (TR).The focus has been on developing transcatheter treatment options for TR considering the substantial short-term mortality (w10%) associated with surgical management of isolated TR. 1 However, recent reports suggested that the adverse outcomes with isolated TR surgery may be mediated by the patient's risk profile and late referral rather than by the surgery itself. 2 We
Authors
- Alyssa Harris
- Alejandra Chavez Ponce (ORCID: https://orcid.org/0000-0002-6685-8339)
- Sahar Samimi (ORCID: https://orcid.org/0000-0003-2133-3106)
- Samian Sulaiman (ORCID: https://orcid.org/0000-0002-1303-6622)
- Ahmed El Shaer (ORCID: https://orcid.org/0000-0002-3368-116X)
- Hasan Alarouri
- Mohamad Adnan Alkhouli (ORCID: https://orcid.org/0000-0003-3847-0959)
Institutions
- Mayo Clinic (US)
- Center for Clinical Research (United States) (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1016/j.jacadv.2024.101319
- Citations
- 3
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.21